Vision Source Pasadena - Medicare Optometrist in Pasadena, TX

Vision Source Pasadena is a medicare enrolled "Optometrist" provider in Pasadena, Texas. Their current practice location is 5233 Fairmont Pkwy, Suite G1, Pasadena, Texas. You can reach out to their office (for appointments etc.) via phone at (281) 487-8100.

Vision Source Pasadena is licensed to practice in Texas (license number 4765TG) and it also participates in the medicare program. Vision Source Pasadena is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1093943292.

Contact Information

Vision Source Pasadena
5233 Fairmont Pkwy, Suite G1,
Pasadena, TX 77505-3947
(281) 487-8100
(281) 487-8103



Healthcare Provider's Profile

Full NameVision Source Pasadena
TypeFacility
SpecialityOptometrist
Location5233 Fairmont Pkwy, Pasadena, Texas
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1093943292
  • Provider Enumeration Date: 06/25/2009
  • Last Update Date: 09/17/2009
  Medicare PECOS Information:
  • PECOS PAC ID: 0042360752
  • Enrollment ID: O20090617000643

Medical Identifiers

Medical identifiers for Vision Source Pasadena such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1093943292NPI-NPPES
0096FFOtherTXBLUE CROSS BLUE SHIELD
0A3988MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist 4765TG (Texas)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Vision Source Pasadena acts as a billing entity for following providers:
Provider NameTammi C Allsep
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1518005297
PECOS PAC ID: 9537219951
Enrollment ID: I20090605000333

News Archive

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Alitair Pharmaceuticals, Inc., today announced that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for its drug candidate, Erdosteine, for the treatment of bronchiectasis. Erdosteine is a mucolytic with antibacterial, anti-inflammatory, and antioxidant properties.

Antidepressants may lower risk of death, complications in people with diabetes and depression

People with diabetes and depression who take antidepressants may have a lower risk of death and of serious diabetes complications, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

Saw Palmetto for enlarged prostate

Physician-scientists are studying an herbal supplement that might aid in reducing the symptoms of an enlarged prostate in men. Recent figures show that benign prostatic hyperplasia (BPH) occurs in an estimated 50 percent of men over the age of 50 and in 75 percent of men 80 and older.

Meaningful PTSD symptom improvement linked to lower risk of type 2 diabetes

Research from Saint Louis University finds treatment for Post-Traumatic Stress Disorder (PTSD) that leads to an improvement in symptoms was associated with a 49 percent lower risk of incident type 2 diabetes.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Vision Source Pasadena is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Vision Source Pasadena
5233 Fairmont Pkwy, Suite G1,
Pasadena, TX 77505-3947

Ph: (281) 487-8100
Vision Source Pasadena
5233 Fairmont Pkwy, Suite G1,
Pasadena, TX 77505-3947

Ph: (281) 487-8100

News Archive

FDA OOPD grants orphan drug designation to Alitair's Erdosteine for treatment of bronchiectasis

Alitair Pharmaceuticals, Inc., today announced that the Office of Orphan Products Development of the Food and Drug Administration has granted orphan drug designation for its drug candidate, Erdosteine, for the treatment of bronchiectasis. Erdosteine is a mucolytic with antibacterial, anti-inflammatory, and antioxidant properties.

Antidepressants may lower risk of death, complications in people with diabetes and depression

People with diabetes and depression who take antidepressants may have a lower risk of death and of serious diabetes complications, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

Saw Palmetto for enlarged prostate

Physician-scientists are studying an herbal supplement that might aid in reducing the symptoms of an enlarged prostate in men. Recent figures show that benign prostatic hyperplasia (BPH) occurs in an estimated 50 percent of men over the age of 50 and in 75 percent of men 80 and older.

Meaningful PTSD symptom improvement linked to lower risk of type 2 diabetes

Research from Saint Louis University finds treatment for Post-Traumatic Stress Disorder (PTSD) that leads to an improvement in symptoms was associated with a 49 percent lower risk of incident type 2 diabetes.

Read more News

› Verified 4 days ago


Optometrist in Pasadena, TX

Shelby Wilkes, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 1008 Southmore Ave Ste 120, Pasadena, TX 77502
Phone: 713-821-3091    
Tia Newsom Budde, OD
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 5125 Fairmont Pkwy, Pasadena, TX 77505
Phone: 713-477-6929    Fax: 281-598-6475
Dr. Kristan L Gibson, OD
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 3333 Bayshore Blvd, Suite 280, Pasadena, TX 77504
Phone: 713-943-8671    Fax: 713-943-1657
Hong Kim Thi Bui, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 201 Pasadena Town Square Mall, Pasadena, TX 77506
Phone: 713-472-7392    Fax: 713-472-2450
Myeyedr.
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 3405 Spencer Hwy, Pasadena, TX 77504
Phone: 281-875-2020    Fax: 713-946-7257
Southmore Texas State Optical
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 825 E Southmore Ave, Pasadena, TX 77502
Phone: 713-473-2020    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.